TTrialPathMatch Me to Trials
← Back to trials
RecruitingNontuberculous Mycobacterium Infection

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

Eligible age

18+ yrs

Accepts

All genders

Locations

10 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)

Sponsor: Chris Goss

You may qualify if…

  • ✓ 1. Written informed consent obtained from participant or participant's legal representative
  • ✓ 2. Be willing and able to adhere to the study visit schedule and other protocol requirements
  • ✓ 3. All genders ≥ 18 years of age at Visit 1
  • ✓ 4. Documentation of a CF diagnosis as evidenced by one or more clinical features consistent with the CF phenotype
  • ✓ 5. Documentation of persistently positive NTM culture results that are positive for the same species or sub-species (either M. avium complex, M. abscessus complex, or both M. avium and M. abscessus). Persistently positive cultures are those which meet ONE of the following criteria, after first ignoring any negative culture results that occur within 7 days of a positive culture:
  • ✓ 1. The two most recent NTM culture results from sputum or BAL taken at least 28 days apart are positive.
  • ✓ OR
  • ✓ 2. At least one NTM culture result in the previous 4 months from sputum or BAL is positive. If there are four or more cultures in the last 12-months at least 3 out of the 4 most recent cultures must be positive for NTM. If there are three or fewer cultures in the past 12 months, then at least 2 of the 3 most recent cultures must be positive for NTM even if some of those cultures are more than 12 months ago.

You may not qualify if…

  • ✕ 1. Any of the following abnormal lab values at screening:
  • ✕ Hemoglobin \<10g/dL
  • ✕ Platelets \<100,000/mm3
  • ✕ Absolute neutrophil count \< 1500/mm3
  • ✕ Aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), or total bilirubin ≥3 x upper limit of normal
  • ✕ Serum creatinine \> 2.0 mg/dl and ≥1.5 x upper limit of normal
  • ✕ Ionized calcium ≤ lower limit of normal (only performed if total calcium is ≤ lower limit of normal)
  • ✕ 2. History of solid organ or hematological transplantation

Where it's recruiting

Alabama

Birmingham

Colorado

Denver

Maryland

Baltimore

Minnesota

Minneapolis

Ohio

Columbus

Pennsylvania

Pittsburgh

South Carolina

Charleston

Texas

Dallas

Vermont

Burlington

Washington

Seattle

Source: ClinicalTrials.gov · NCT04294043 · last updated 2025-10-01